Thymoma in Myasthenia Gravis: From Diagnosis to Treatment
Well Cited
157
Citations47
Refs2011
Year
Search Works
Work Details
- DOI 10.4061/2011/474512
- PMID https://pubmed.ncbi.nlm.nih.gov/21860784
- PMCID https://www.ncbi.nlm.nih.gov/pmc/articles/3155972
- OpenAlex ID W1977401045
- Type Article
- Language EN
- Published 01 Jan 2011
- Volume 2011
- Pages 1–5
- Source Autoimmune Diseases
- Publisher Hindawi Publishing Corporation
- FWCI 3.65
- Countries 1
- Institutions 1
- Added 24 Jun 2016
- Updated 28 Oct 2026
External Links
MENU
0
Thymoma in Myasthenia Gravis: From Diagnosis to Treatment
Article 2011 EN Gold
One half of cortical thymoma patients develop myasthenia gravis (MG), while 15% of MG patients have thymomas. MG is a neuromuscular junction disease caused in 85% of the cases by acetylcholine receptor (AChR) antibodies. Titin and ryanodine receptor (RyR) antibodies are found in 95% of thymoma MG and 50% of late-onset MG (MG onset ≥50 years), are associated with severe disease, and may predict thy…
157
Citations
47
References
1
Authors
3.65
FWCI
Citations by Year
Last 15 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
1 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Fredrik Robert Romi Corresponding | Haukeland University Hospital (NO) | — |
Related Works
10Data: OpenAlex